John Bowler Fitzgibbons

John Bowler Fitzgibbons is the founder and chairman of Basin Holdings, comprising a group of controlled, privately-held companies active in energy and industrial manufacturing. He is also the founder and chairman of Talus Group Holdings, comprising a group of controlled, privately-held companies active in a broad range of markets and geographies.

John Bowler Fitzgibbons
Born
John Bowler Fitzgibbons
EducationHarvard University
Occupation(s)Founder and Chairman of Basin Holdings; Founder and Chairman of Talus Group Holdings; Co-Founder and Partner of Deerpath Capital

Education

edit

Fitzgibbons attended Harvard University, graduating cum laude with a B.A. in government.[1]

Career

edit

Fitzgibbons founded, managed, and sold several businesses in the Russian energy market, including Khanty Mansiysk Oil Corporation (KMOC), which sold to Marathon Oil Corporation in 2003, and Integra Group, which was taken public on the London Stock Exchange in 2007.

In 2007, Fitzgibbons co-founded Deerpath Capital, a fund management group focused on direct lending in the US middle market, where he is currently a partner.[2]

In 2010, Fitzgibbons founded Basin Holdings and in 2012, he founded Talus Group Holdings.[3]

Philanthropy

edit

Fitzgibbons currently serves on the board of trustees at Milton Academy. [4] He is also a member of the Council on Foreign Relations.[5] Fitzgibbons formerly served as chairman of The SUNY Research Foundation and co-chairman of the Cancer Research Institute.[6] [7]

References

edit
  1. ^ "Milton Magazine "A Timely Risk: Gaining Expertise in the Western Siberian Basin" (PDF). Archived from the original (PDF) on 2010-12-18. Retrieved 2014-02-20.
  2. ^ "Deerpath Capital". Retrieved 2022-04-29.
  3. ^ "Basin Holdings - About Us". Retrieved 2014-02-20.
  4. ^ "Milton Leadership". Archived from the original on 2014-03-16. Retrieved 2014-02-20.
  5. ^ "Council on Foreign Relations Member Roster". Retrieved 2014-02-20.
  6. ^ "SUNY Research Foundation Board". Retrieved 2014-02-20.
  7. ^ "Cancer Research Institute Board". Retrieved 2014-02-20.